Lumida
/ANIK
⌘K
Anika Therapeutics Inc

Anika Therapeutics Inc

ANIK
$15.25USD-3.60%-0.57 today

MARKET CAP

202.9M

P/E (TTM)

FWD P/E

DAY RANGE

$15 – $16

52W RANGE

$8
$16

AI Summary

Stalk
Sell NowMedium

ANIK is in a Stage 3 distribution phase, granting bearish medium-term permission. Short-term price is rejecting around the 9/21 EMAs and 50-day SMA, reflecting diminishing demand and structure failure. The preferred execution is selling into rallies near these resistance zones, aligning with the dominant downtrend while respecting potential short-term oversold bounces.

  • Q1 2026 commercial channel revenue grew 12% YoY to $12.6M.
  • Gross margins expanded to 64% from 56% via productivity gains.
  • Q1 OEM channel revenue declined 23% YoY from pricing pressure.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRIC
TREND